enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. New treatment may stop and potentially reverse some nerve ...

   www.aol.com/treatment-may-stop-potentially...

   Scientists have developed a new treatment that may help regenerate myelin around nerve cells, and potentially reverse the damage caused by multiple sclerosis ... 2024 at 7:41 AM.

3. Multiple sclerosis drug pipeline - Wikipedia

   en.wikipedia.org/wiki/Multiple_sclerosis_drug...

   The conventional explanation of such protection is that parasites (including bacteria) modulate the sensitivity of the immune system. BCG appears safe as a treatment for multiple sclerosis. [100] [102] Low dose naltrexone is also known as LDN. Naltrexone, a pure opiate antagonist, licensed by the FDA for the treatment of alcohol and opioid ...

4. Research in multiple sclerosis - Wikipedia

   en.wikipedia.org/wiki/Research_in_multiple_sclerosis

   Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis. There ...

5. Stem-cell therapy - Wikipedia

   en.wikipedia.org/wiki/Stem-cell_therapy

   The natural movement promoted the alignment of the new fibers and tendocytes with the natural alignment found in uninjured tendons. Stem cell treatment not only allowed more horses to return to full duty and also greatly reduced the re-injury rate over a three-year period. [23] The use of embryonic stem cells has also been applied to tendon repair.

6. 19 drug approvals in 2024 that had 'big clinical impact ... - AOL

   www.aol.com/news/19-drug-approvals-2024-had...

   GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are “slated to make a big clinical impact."

7. Laquinimod - Wikipedia

   en.wikipedia.org/wiki/Laquinimod

   It is being investigated as an oral treatment for multiple sclerosis (MS) and Huntington's disease. Laquinimod is the successor of Active Biotech's failed experimental immunomodulator linomide. [1] The compound has been investigated in two Phase II trials using successive magnetic resonance scans (MRI). Laquinimod seems to be able to reduce the ...